ROPHARMA
65 articole · RSS
Ropharma 1H Profit Down 41%
Romanian generic drugs wholesaler Ropharma Brașov (RPH.RO) Friday announced sales of 207.48 million lei (EUR47.2 million) in the first six months, up 10% on the year, and profit of RON4.38 m...
Ropharma Net Profit Falls To RON1.5M
Romanian generic drugs wholesaler Ropharma Brașov (RPH.RO) Tuesday said its net profit fell to 1.5 million lei (EUR0.34 million) in the first quarter, from RON6 million in the year-earlier p...
Ropharma Owner Set To Boost Production To 10% Of Turnover
Businessman Mihai Miron, who controls pharmaceutical company Ropharma, says he plans to have production growth outstrip total turnover growth this year. This is the first time Mihai Miron ha...
Ropharma Eyes 20% Higher Profit In 2012
Romanian generic drugs wholesaler Ropharma Brasov estimates its net profit will rise 20% to 12.8 million lei (EUR2.9 million) in 2012, supported by a 12% increase in sales.
Ropharma Net Profit Slides 3.3% To RON10.5M In 2011
Romanian generic drugs wholesaler Ropharma Brașov (RPH.RO) Tuesday said its net profit fell 3.3% on the year to 10.52 million lei (EUR2.5 million) in 2011, despite higher sales.
Ropharma Borrows EUR2M To Finance Investments
Romanian generic drugs wholesaler Ropharma Brasov (RPH.RO) will borrow up to EUR2 million from ING Bank to finance investments, the company said in a statement Monday.
Ropharma’s Worst Case Scenario Sees 15% Rise In Sales For 2012
Businessman Mihai Miron, who controls medicine wholesaler Ropharma (RPH.RO), with an annual turnover of around RON400 million (around EUR92 million), says he is working with two budget versi...
Ropharma Net Profit Falls 29% In January-September
Romanian generic drugs wholesaler Ropharma Brașov (RPH.RO) Monday said its net profit dropped 29% on the year to 8.6 million lei (EUR2 million) in the first nine months, on higher operating...
Ropharma Eyes EUR2M Loan To Finance Investments
Romanian generic drugs wholesaler Ropharma Brasov (RPH.RO) plans to borrow EUR2 million from ING Bank to finance medium-term investments, the company said in a statement Friday.